CAS clears Halep for immediate return following doping ban reduction

The top court for global sport reduced former Wimbledon and French Open champion Simona Halep's four-year doping ban to nine months on Tuesday, allowing the former world number one to compete immediately.

Halep was initially banned for four years due to two separate anti-doping rule violations. However, the Lausanne-based Court of Arbitration for Sport (CAS) determined that her suspension should be reduced to nine months, which she has already served.

"The CAS Panel has unanimously determined that the four-year period of ineligibility... is to be reduced to a period of ineligibility of nine (9) months starting on 7 October 2022, which period expired on 6 July 2023," CAS said.

Now that the 32-year-old Romanian is eligible to compete, she could be given a wildcard to this year's French Open or Wimbledon.

"Throughout this long and difficult process, I have maintained my belief that the truth would eventually come out, and that a just decision would be reached, because I am and always have been a clean athlete," Halep said in a statement.

"I cannot wait to return to the tour."

Halep was suspended in October 2022 after testing positive for roxadustat, a banned drug that stimulates red blood cell production, at the United States Open that year.

She was also charged with another doping offense last year due to irregularities in her athlete biological passport (ABP), which is a method for monitoring various blood parameters over time to detect potential doping.

Halep, who has vehemently denied the charges against her, has stated that if the initial four-year ban is upheld, she will almost certainly have to retire.

Halep blamed her positive test at the US Open on contaminated supplements and accused the International Tennis Integrity Agency (ITIA) of charging her with an ABP violation after the experts who reviewed her profile discovered her identity.

In response to the ruling, ITIA Chief Executive Officer Karen Moorhouse stated, "An essential element of the anti-doping process is a player's ability to appeal, and the ITIA respects both their right to do so and the outcome."

An independent tribunal accepted Halep's claim that she had taken contaminated supplements, but determined that the volume she consumed could not have resulted in the concentration of roxadustat found in her positive sample.

However, the CAS Panel determined that, while Halep should have been more careful when using the supplement, she did not bear significant responsibility for the violation.

Furthermore, the ABP charge was dismissed on the grounds that it was reasonable to consider that the sample given in late 2022 was shortly before a surgery and Halep had stated that she would not compete for the remainder of that year.

The Professional Tennis Players Association said the CAS decision "underscores the need for sensible reform to an unjust system that fails to protect (the players' rights)."

SportsLigue